• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Time course of various cell origin circulating microparticles in ST-segment elevation myocardial infarction patients undergoing percutaneous transluminal coronary intervention.接受经皮冠状动脉腔内血管成形术的ST段抬高型心肌梗死患者中不同细胞来源循环微粒的时间进程。
Exp Ther Med. 2016 Apr;11(4):1481-1486. doi: 10.3892/etm.2016.3060. Epub 2016 Feb 9.
2
Effect of abciximab on the levels of circulating microparticles in patients with acute myocardial infarction treated by primary angioplasty.阿昔单抗对行直接经皮冠状动脉介入治疗的急性心肌梗死患者循环微颗粒水平的影响。
Korean Circ J. 2013 Sep;43(9):600-6. doi: 10.4070/kcj.2013.43.9.600. Epub 2013 Sep 30.
3
Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者罪犯冠状动脉抽吸微颗粒的局部增加。
Atherosclerosis. 2013 Apr;227(2):323-8. doi: 10.1016/j.atherosclerosis.2013.01.032. Epub 2013 Feb 5.
4
Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation.ST段抬高型心肌梗死患者闭塞冠状动脉内促凝组织因子携带微粒水平升高:内皮损伤和白细胞激活的作用
Atherosclerosis. 2009 Jun;204(2):636-41. doi: 10.1016/j.atherosclerosis.2008.10.039. Epub 2008 Nov 12.
5
Effect of Thrombolysis on Circulating Microparticles in Patients with ST-Segment Elevation Myocardial Infarction.溶栓治疗对 ST 段抬高型心肌梗死患者循环微颗粒的影响。
Cardiovasc Ther. 2023 Nov 18;2023:5559368. doi: 10.1155/2023/5559368. eCollection 2023.
6
Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time.ST段抬高型心肌梗死患者冠状动脉血与外周血中循环微粒特征与疼痛至经皮冠状动脉介入治疗时间的关系
Int J Cardiol. 2016 Jan 1;202:378-87. doi: 10.1016/j.ijcard.2015.09.011. Epub 2015 Sep 12.
7
Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.急性冠状动脉综合征中小粒径循环微颗粒:与纤溶状态、修复标志物及预后的相关性。
Atherosclerosis. 2013 Apr;227(2):313-22. doi: 10.1016/j.atherosclerosis.2013.01.028. Epub 2013 Jan 29.
8
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention.经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的冠状动脉内微颗粒和微血管阻塞。
Eur Heart J. 2012 Dec;33(23):2928-38. doi: 10.1093/eurheartj/ehs065. Epub 2012 Mar 27.
9
Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.血小板磷脂酰丝氨酸暴露增加和循环微颗粒导致颈动脉支架置入术后促凝活性增强。
J Neurosurg. 2017 Nov;127(5):1041-1054. doi: 10.3171/2016.8.JNS16996. Epub 2016 Dec 23.
10
Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.残余血小板反应性对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者再灌注的影响。
Eur Heart J Acute Cardiovasc Care. 2016 Sep;5(5):475-86. doi: 10.1177/2048872615624849. Epub 2016 Jan 12.

引用本文的文献

1
Procoagulant effect of extracellular vesicles in patients after transcatheter aortic valve replacement or transcatheter aortic valve replacement with percutaneous coronary intervention.经导管主动脉瓣置换术或经导管主动脉瓣置换术联合经皮冠状动脉介入治疗患者细胞外囊泡的促凝作用。
J Thromb Thrombolysis. 2023 Aug;56(2):264-274. doi: 10.1007/s11239-023-02835-5. Epub 2023 Jun 7.
2
Microparticles and cardiovascular diseases.微粒与心血管疾病。
Ann Med. 2019 May-Jun;51(3-4):193-223. doi: 10.1080/07853890.2019.1609076. Epub 2019 Jun 17.
3
Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes.分子机制为糖尿病相关心血管并发症中微粒介导的细胞损伤提供了理论基础。
Oxid Med Cell Longev. 2019 Feb 19;2019:6475187. doi: 10.1155/2019/6475187. eCollection 2019.

本文引用的文献

1
Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation.脂蛋白(a)在预测2型糖尿病患者新发冠状动脉疾病严重程度中的作用:一项Gensini评分评估。
Diab Vasc Dis Res. 2015 Jul;12(4):258-64. doi: 10.1177/1479164115579004. Epub 2015 Apr 10.
2
Effects of tirofiban on platelet activation and endothelial function in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.替罗非班对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者血小板活化及内皮功能的影响。
Cell Biochem Biophys. 2015 Jan;71(1):135-42. doi: 10.1007/s12013-014-0173-4.
3
Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study.微粒与冠状动脉闭塞所致的心源性猝死。TIDE(心源性猝死中的血栓与炎症)研究。
Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):28-36. doi: 10.1177/2048872614538404. Epub 2014 Jun 9.
4
Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction.循环微颗粒在心肌梗死患者中生成并转运单体 C 反应蛋白。
Cardiovasc Res. 2012 Oct 1;96(1):64-72. doi: 10.1093/cvr/cvs237. Epub 2012 Jul 13.
5
Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.白细胞和内皮细胞衍生的微颗粒:纤维蛋白溶解的循环来源。
Haematologica. 2012 Dec;97(12):1864-72. doi: 10.3324/haematol.2012.066167. Epub 2012 Jun 24.
6
Differences in microparticle release in patients with acute coronary syndrome and stable angina.急性冠脉综合征与稳定性心绞痛患者微粒释放的差异。
Circ J. 2012;76(9):2174-82. doi: 10.1253/circj.cj-12-0068. Epub 2012 Jun 5.
7
Dynamic changes in serum angiopoietin-1, angiopoietin-2, and angiopoietin-2/angiopoietin-1 ratio in acute myocardial infarction patients treated with primary percutaneous coronary intervention.急性心肌梗死患者经皮冠状动脉介入治疗后血清血管生成素-1、血管生成素-2 及血管生成素-2/血管生成素-1 比值的动态变化。
Biomarkers. 2012 Aug;17(5):441-6. doi: 10.3109/1354750X.2012.684152. Epub 2012 May 30.
8
Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation.微粒作为循环中促凝和纤溶活性的循环来源。
Thromb Res. 2012 May;129 Suppl 2:S27-9. doi: 10.1016/j.thromres.2012.02.025. Epub 2012 Mar 16.
9
High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles--brief report.高敏流式细胞术提供了标准化测量小尺寸微颗粒的途径——简短报告。
Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):1054-8. doi: 10.1161/ATVBAHA.111.244616. Epub 2012 Feb 9.
10
Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation.急性心肌梗死和稳定型心绞痛期间产生的微颗粒数量与血小板活化相关。
Arch Med Res. 2012 Jan;43(1):31-5. doi: 10.1016/j.arcmed.2012.01.006. Epub 2012 Feb 2.

接受经皮冠状动脉腔内血管成形术的ST段抬高型心肌梗死患者中不同细胞来源循环微粒的时间进程。

Time course of various cell origin circulating microparticles in ST-segment elevation myocardial infarction patients undergoing percutaneous transluminal coronary intervention.

作者信息

Zhou Boda, Li Jizhao, Chen Shaomin, Zhou Enchen, Zheng Lemin, Zu Lingyun, Gao Wei

机构信息

Department of Cardiovascular Medicine, Peking University Third Hospital, Beijing 100191, P.R. China.

Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Peking University Health Science Center, Beijing 100191, P.R. China.

出版信息

Exp Ther Med. 2016 Apr;11(4):1481-1486. doi: 10.3892/etm.2016.3060. Epub 2016 Feb 9.

DOI:10.3892/etm.2016.3060
PMID:27073469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4812389/
Abstract

The present study aimed to investigate the time course of changes in microparticles (MPs) in patients with ST-segment elevation myocardial infarction (STEMI) that underwent percutaneous transluminal coronary intervention (PCI). A total of 24 STEMI patients undergoing primary PCI were enrolled, and circulating MPs were detected immediately prior to and after PCI, and at 4, 24 and 48 h post-PCI. Standard Megamix beads, based measurement protocols, were employed to measure MPs of different cell origin, including endothelial MPs (EMPs), platelet MPs (PMPs) and leukocyte-derived MPs (LMPs), which were identified by CD144, CD41 and CD45, respectively. The results indicated that PMP levels were evidently elevated immediately after PCI, and reached a maximum level at 48 h. In addition, LMP and EMP levels were significantly decreased immediately after the PCI, and then increased gradually with time. The total quantity of the three aforementioned MP types increased gradually at 48 h following PCI. Furthermore, coronary angiographic Gensini scores were significantly positively correlated with the level of PMPs (r2=0.42; P=0.0006). Log-normalized high sensitivity-C-reactive-protein was also significantly correlated with LMPs (r2=0.86; P<0.01). In conclusion, the time course of the changes in circulating MPs of different cell origin, provided information on possible functions of different MPs in STEMI.

摘要

本研究旨在调查接受经皮冠状动脉腔内血管成形术(PCI)的ST段抬高型心肌梗死(STEMI)患者体内微粒(MPs)的变化时间进程。共纳入24例接受直接PCI的STEMI患者,在PCI术前、术后即刻以及术后4、24和48小时检测循环MPs。采用基于标准Megamix微珠的测量方案来测量不同细胞来源的MPs,包括内皮微粒(EMPs)、血小板微粒(PMPs)和白细胞衍生微粒(LMPs),分别通过CD144、CD41和CD45进行鉴定。结果表明,PMP水平在PCI术后即刻明显升高,并在48小时达到最高水平。此外,LMP和EMP水平在PCI术后即刻显著降低,然后随时间逐渐升高。上述三种MP类型的总量在PCI术后48小时逐渐增加。此外,冠状动脉造影Gensini评分与PMPs水平显著正相关(r2 = 0.42;P = 0.0006)。对数标准化高敏C反应蛋白也与LMPs显著相关(r2 = 0.86;P < 0.01)。总之,不同细胞来源的循环MPs变化时间进程,为STEMI中不同MPs的可能功能提供了信息。